Jiangsu Nanfang Medical Co (SHSE:603880) Debt-to-Equity : 1.78 (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Jiangsu Nanfang Medical Co Debt-to-Equity?

Jiangsu Nanfang Medical Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥464.7 Mil. Jiangsu Nanfang Medical Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥17.1 Mil. Jiangsu Nanfang Medical Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ¥271.4 Mil. Jiangsu Nanfang Medical Co's debt to equity for the quarter that ended in Mar. 2025 was 1.78.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Jiangsu Nanfang Medical Co's Debt-to-Equity or its related term are showing as below:

SHSE:603880' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.21 Med: 0.54 Max: 1.78
Current: 1.78

During the past 13 years, the highest Debt-to-Equity Ratio of Jiangsu Nanfang Medical Co was 1.78. The lowest was 0.21. And the median was 0.54.

SHSE:603880's Debt-to-Equity is ranked worse than
93.52% of 694 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs SHSE:603880: 1.78

Jiangsu Nanfang Medical Co Debt-to-Equity Historical Data

The historical data trend for Jiangsu Nanfang Medical Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Nanfang Medical Co Debt-to-Equity Chart

Jiangsu Nanfang Medical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Equity

Get a 7-Day Free Trial

0.26

0.56

0.77

1.00

1.78

Jiangsu Nanfang Medical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Debt-to-Equity	Get a 7-Day Free Trial															0.99	1.14	1.14	1.78	1.78

Competitive Comparison of Jiangsu Nanfang Medical Co's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, Jiangsu Nanfang Medical Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jiangsu Nanfang Medical Co's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Jiangsu Nanfang Medical Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Jiangsu Nanfang Medical Co's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Jiangsu Nanfang Medical Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Jiangsu Nanfang Medical Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(475.799	+	21.135)	/	279.287
	=	1.78

Jiangsu Nanfang Medical Co's Debt to Equity Ratio for the quarter that ended in Mar. 2025 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(464.731	+	17.135)	/	271.401
	=	1.78

Jiangsu Nanfang Medical Co (SHSE:603880) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Jiangsu Nanfang Medical Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Jiangsu Nanfang Medical Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Nanfang Medical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jiangsu Nanfang Medical Co Ltd (SHSE:603880) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Guo Xiang Road, Economic Development Zone, Jiangsu Province, Wujin, CHN, 213149

Website

http://www.nfmedical.com.cn

Jiangsu Nanfang Medical Co Ltd is a domestic adhesive dressing production enterprise that integrates research and development, production, and sales. It produces a band-aid in China. The company is focused on the development of self-owned brand products such as first-aid kits, sports protection products, and care products on the basis of the original series of Miaoshou medical dressings.

Executives

Zhou Min	Director
Li Ping	Director
Xiang Qin Hua	Director
Li Fei	Director
Wu Ya Fen	senior management
Li Yong Ping	Director
Zhuang Guo Ping	Director
Li Yong Zhong	Director
Li Yan Hua	Director

Jiangsu Nanfang Medical Co Headlines

No Headlines